International safety notice
Medicines containing 5-fluorouracil (i.v.) - In patients with moderate to severe renal impairment, interpret DPD deficiency phenotyping (via blood uracil levels) with caution
Ireland / HPRA · IRL · Oct 23, 2024
Key facts
| Title | Medicines containing 5-fluorouracil (i.v.) - In patients with moderate to severe renal impairment, interpret DPD deficiency phenotyping (via blood uracil levels) with caution |
|---|---|
| Regulator | Ireland / HPRA |
| Country | IRL |
| Brand | Medicines containing 5-fluorouracil (i.v.) - In patients with moderate to severe renal impairment, interpret DPD deficiency phenotyping (via blood uracil levels) with caution |
| Models | 1271385257, 616161, 5-FLUOROURACIL |
| Date | Oct 23, 2024 |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1